Cue Biopharma Current Deferred Revenue (Quarterly) Analysis

Cue Biopharma, Inc. (CUE)

0.3139 +0.01 (+3.80%) USD | NASDAQ | Dec 31, 14:49

View Current Deferred Revenue (Quarterly) for CUE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Puma Biotechnology, Inc.	--
Mersana Therapeutics, Inc.	Upgrade
Adaptive Biotechnologies Corp.	Upgrade
NovaBay Pharmaceuticals, Inc.	--